Clinical Trial Update: TSN222 in Subjects With Advanced Solid Tumors or Lymphomas [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trials are evaluating TSN222 in adults with unresectable locally advanced or metastatic solid tumors or lymphoma, and the study is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Unresectable Locally Advanced or Metastatic Solid Tumors

Drugs mentioned

• TSN222

Snippet

Sponsor: Tyligand Bioscience (Shanghai) Limited | Conditions: Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma | Phase 1, Phase 2 | Status: RECRUITING